Escitalopram (Lexapro) consistently ranks as the most effective SSRI for generalized anxiety disorder in head-to-head comparisons. In a large network meta-analysis published in the Journal of Psychiatric Research, escitalopram produced the greatest reduction in anxiety symptoms among all first-line medications tested, lowering scores on a standardized anxiety scale by an average of 3.2 points more than placebo. But “best” depends on more than just raw effectiveness. The type of anxiety you have, how you respond to side effects, and whether you plan to stay on medication long-term all shape which SSRI makes the most sense for you.
How SSRIs Compare by Anxiety Type
Not every SSRI is approved for every anxiety disorder, and the evidence supporting each one varies depending on whether you’re dealing with generalized worry, panic attacks, social anxiety, or OCD. Here’s how the main options break down by condition:
- Generalized anxiety disorder (GAD): Escitalopram and paroxetine both carry FDA approval for GAD. Escitalopram edges ahead in efficacy data and is generally better tolerated.
- Panic disorder: Sertraline, paroxetine, and fluoxetine are all FDA-approved. A network meta-analysis in the Asian Journal of Psychiatry found escitalopram had the strongest efficacy and acceptability profile for panic disorder as well, even though its formal FDA indication is limited to GAD.
- Social anxiety disorder: Sertraline and paroxetine are the FDA-approved options here.
- OCD: Fluvoxamine, fluoxetine, sertraline, and paroxetine all carry OCD indications. Fluvoxamine is sometimes preferred because it was developed specifically with OCD in mind, though sertraline and fluoxetine are prescribed more broadly.
If your anxiety doesn’t fit neatly into one category, escitalopram or sertraline are the most common starting points because they cover the widest range of anxiety symptoms with relatively manageable side effects.
What to Expect in the First Few Weeks
SSRIs don’t work overnight, and the first two weeks can feel counterintuitive. In a study of 201 patients starting SSRI treatment, about 49% noticed some improvement in anxiety by week two, 36% felt roughly the same, and nearly 15% actually felt more anxious during that initial adjustment period. This temporary worsening is a recognized part of starting treatment, not a sign the medication isn’t working.
Clinicians typically recommend starting at a lower dose for anxiety than for depression and increasing slowly. For escitalopram, that means beginning at 5 to 10 mg per day, with a target range of 10 to 30 mg. Sertraline usually starts at 25 mg, working up to 50 to 200 mg. This gradual approach helps minimize the early jitteriness that makes some people quit before the medication has a real chance. Most people see significant improvement by six to eight weeks.
Side Effects That Differ Between SSRIs
All SSRIs share a common side effect profile: nausea, headaches, sleep disruption, and sexual problems are the most frequent complaints. But the severity varies meaningfully from one drug to the next.
Sexual side effects are the reason many people switch medications or stop altogether. Paroxetine has the highest rates, affecting roughly 65 to 71% of users depending on the study. Sertraline falls in the 56 to 63% range, and fluoxetine sits around 54 to 58%. Escitalopram and citalopram land in a similar range to sertraline. These numbers are high across the board, but if sexual function is a priority, paroxetine is the one most likely to cause problems.
Weight changes are harder to pin down with specific numbers. Paroxetine is the SSRI most commonly associated with weight gain over time. Fluoxetine tends to be weight-neutral or even associated with modest weight loss in the short term, which is one reason it remains popular despite not being the strongest option for anxiety specifically.
Why Stopping Matters When Choosing
One of the most overlooked factors in choosing an SSRI is how difficult it is to stop. Every SSRI can cause discontinuation symptoms (dizziness, irritability, “brain zaps,” flu-like feelings), but the risk varies dramatically based on how quickly the drug leaves your body.
Paroxetine is the worst offender. In one randomized trial comparing three SSRIs, 66% of paroxetine users experienced discontinuation symptoms, compared to 60% for sertraline and just 14% for fluoxetine. Prescription data from the United Kingdom showed paroxetine’s discontinuation rate was over 100 times higher than fluoxetine’s per prescription written.
The reason comes down to half-life, which is how long a drug stays active in your system. Fluoxetine has a half-life of roughly 4 to 6 days, and its active byproduct lingers for up to 16 days. That creates a built-in taper, so your body adjusts gradually even if you miss doses or stop. Paroxetine’s half-life is only about 21 hours with no active byproduct, so levels drop sharply. Escitalopram and sertraline fall in the middle, with half-lives of around 30 and 26 hours respectively. If you anticipate wanting to try medication for a defined period and then stop, fluoxetine or escitalopram are generally easier to come off of than paroxetine.
Drug Interactions to Be Aware Of
Fluoxetine and paroxetine both strongly inhibit a liver enzyme called CYP2D6, which your body uses to process a wide range of other medications, from certain blood pressure drugs to pain relievers. If you take other prescriptions, this matters. Escitalopram and sertraline are milder on this enzyme system, making them safer choices for people on multiple medications. This is one practical reason escitalopram and sertraline are so frequently chosen as first-line options.
A Realistic Way to Think About “Best”
If you’re looking for a single answer, escitalopram has the strongest efficacy data for generalized anxiety, a moderate side effect profile, a manageable discontinuation risk, and fewer drug interactions than most alternatives. Sertraline is a close second with broader FDA indications across anxiety subtypes. These two are the most commonly prescribed SSRIs for anxiety for good reason.
That said, individual response to SSRIs is unpredictable. Two people with identical anxiety symptoms can respond completely differently to the same medication. It’s common to try one SSRI, find it doesn’t work well or causes intolerable side effects, and switch to another that works much better. About 40 to 50% of people respond well to the first SSRI they try, which means the other half end up adjusting the dose or switching.
If you’ve tried one SSRI and it didn’t help after a full 6 to 8 weeks at an adequate dose, that doesn’t mean SSRIs won’t work for you. It usually means a different one is worth trying. The gap between the “best on average” and the “best for you” is something only trial and adjustment can close.